¥312.00
2.50%
Tokyo, Sep 29, 11:30 am JST. Closed.
ISIN
JP3423580004
Symbol
4880

Cellsource Co.,ltd. Stock price

¥320.00
-23.00 6.71% 1M
-50.00 13.51% 6M
-79.00 19.80% YTD
-247.00 43.56% 1Y
-2,020.24 86.33% 3Y
-5,912.69 94.87% 5Y
-454.12 58.66% 10Y
-454.12 58.66% 20Y
Tokyo, Closing price Mon, Sep 28 2026
-5.00 1.54%

Is Cellsource Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥6.5b
Enterprise Value
¥1.7b
Net debt
positive
Cash
¥4.8b
Shares outstanding
19.9m
Valuation (TTM | estimate)
P/E
90.1
P/S
1.8 | 1.8
EV/Sales
0.5 | 0.5
EV/FCF
5.2
P/B
1.1
Dividends
DPS
¥5.00
Yield 1Y | 5Y
1.6% | 0.1%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
41.8% | 22.2%
Increased
0 Years
Financials (TTM | estimate)
Revenue
¥3.7b | ¥3.6b
EBITDA
¥463.0m
EBIT
¥275.3m
Net Income
¥70.7m
Free Cash Flow
¥321.8m
Growth (TTM | estimate)
Revenue
-7.1% | -2.0%
EBITDA
834.3%
EBIT
303.6%
Net Income
238.9%
Free Cash Flow
35,853.3%
Margin
Gross
57.6%
EBITDA
12.6%
EBIT
7.5%
Net
1.9%
Free Cash Flow
8.8%
Financial Health
Equity Ratio
85.7%
Return on Equity
0.2%
ROCE
4.3%
ROIC
5.7%
Debt/Equity
0.0
More
EPS
¥3.6
FCF per Share
¥16.2
Short interest
-
Employees
148
Rev per Employee
¥25.1m

Cellsource Co.,ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Cellsource Co.,ltd. forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a Cellsource Co.,ltd. forecast:

Hold
43%
Sell
57%

Financial data from Cellsource Co.,ltd.

Apr '26
+/-
%
3,667 3,667
7% 7%
100%
- Direct Costs 1,556 1,556
20% 20%
42%
2,111 2,111
5% 5%
58%
- Selling and Administrative Expenses 1,366 1,366
36% 36%
37%
- Research and Development Expense - -
-
-
463 463
834% 834%
13%
- Depreciation and Amortization 188 188
2% 2%
5%
EBIT (Operating Income) EBIT 275 275
304% 304%
8%
Net Profit 71 71
239% 239%
2%

In millions JPY.

Don't miss a Thing! We will send you all news about Cellsource Co.,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CellSource Co., Ltd. engages in regenerative medicine related business. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 148 full-time employees. The company went IPO on 2019-10-28. The firm operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

Head office Japan
CEO Mr. Sawada
Employees 148
Website www.cellsource.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today